Non-selective NSAID
Indometacin
Adult dose
Dose: 50–200mg/day in divided doses; max 200mg/day. Acute gout: 150–200mg/day initially. PDA closure (neonatal): specialist
Route: PO/PR/IV
Frequency: divided
Clinical pearls
- Acute gout (alternative to colchicine/naproxen)
- Neonatal PDA closure (specialist)
Contraindications
- Active GI bleeding
- Severe heart failure
- Severe renal/hepatic impairment
- Aspirin/NSAID hypersensitivity
- Late pregnancy
Side effects
- GI upset/bleeding
- Headache
- Renal impairment
- Cardiovascular events
- CNS effects (rare)
Interactions
- Anticoagulants/antiplatelets
- ACEi/ARB
- Lithium
- Methotrexate
Monitoring
- U&E
- FBC if prolonged
Reference: BNF; https://bnf.nice.org.uk/drugs/indometacin/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022